AstraZeneca PLC (AZN)
65.63
+1.37
(+2.13%)
USD |
NASDAQ |
Nov 22, 16:00
65.64
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Revenue (Annual): 45.81B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.81B |
| December 31, 2022 | 44.35B |
| December 31, 2021 | 37.42B |
| December 31, 2020 | 26.62B |
| December 31, 2019 | 24.38B |
| December 31, 2018 | 22.09B |
| December 31, 2017 | 22.46B |
| December 31, 2016 | 23.00B |
| December 31, 2015 | 24.71B |
| December 31, 2014 | 26.55B |
| December 31, 2013 | 25.81B |
| December 31, 2012 | 27.97B |
| December 31, 2011 | 33.59B |
| December 31, 2010 | 33.27B |
| December 31, 2009 | 32.80B |
| December 31, 2008 | 31.60B |
| December 31, 2007 | 29.56B |
| Date | Value |
|---|---|
| December 31, 2006 | 26.48B |
| December 31, 2005 | 23.95B |
| December 31, 2004 | 21.43B |
| December 31, 2003 | 18.85B |
| December 31, 2002 | 17.84B |
| December 31, 2001 | 16.48B |
| December 31, 2000 | 18.12B |
| December 31, 1999 | 15.13B |
| December 31, 1998 | 11.32B |
| December 31, 1997 | 8.586B |
| December 31, 1996 | 9.184B |
| December 31, 1995 | 7.568B |
| December 31, 1994 | 7.004B |
| December 31, 1993 | 6.568B |
| December 31, 1992 | 6.035B |
| December 31, 1991 | 7.352B |
| December 31, 1990 | 7.349B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
24.38B
Minimum
2019
45.81B
Maximum
2023
35.72B
Average
37.42B
Median
2021
Revenue (Annual) Benchmarks
| GSK PLC | 37.74B |
| Amgen Inc | 28.19B |
| Johnson & Johnson | 85.16B |
| Sanofi SA | 50.28B |
| Moderna Inc | 6.754B |